(Q46672529)

24 December 2017

title

Simple pharmacological test battery to assess efficacy and side effect profile of centrally acting muscle relaxant drugs (English)

1 reference

24 December 2017

1 reference

Sándor Farkas

1

1 reference

24 December 2017

Pál Berzsenyi

2

1 reference

24 December 2017

Egon Kárpáti

3

1 reference

24 December 2017

Pál Kocsis

4

1 reference

24 December 2017

István Tarnawa

5

1 reference

24 December 2017

publication date

12 January 2005

1 reference

24 December 2017

Journal of Pharmacological and Toxicological Methods

published in

1 reference

24 December 2017

volume

52

1 reference

24 December 2017

issue

2

1 reference

24 December 2017

page(s)

264-273

1 reference

24 December 2017

Citalopram, a selective serotonin reuptake inhibitor augments harmaline-induced tremor in rats

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.11.005

The production of an alternative laboratory model of the Parkinson syndrome using a new benzylimidoylurea derivative LON 954

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.11.005

Central transmitter involvement in LON-954-induced tremorogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.11.005

The differential effects of baclofen on segmental and descending excitation of spinal interneurones in the cat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.11.005

A comparative study of dantrolene sodium and other skeletal muscle relaxants with the straub tail mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.11.005

Validation of a new computerized system for recording and analysing drug-induced tremor in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.11.005

Harmine-, LON-954- and 5-hydroxytryptophan-induced tremors in rats withdrawn from ethanol.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.11.005

Dopamine D2 receptors and spinal cord excitation in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.11.005

Intrathecal morphine in mice: a new technique

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.11.005

Pharmacological effects of 1,3-dimethyl-5-aminoadamantane, a new adamantane derivative

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.11.005

Long-lasting muscle relaxant activity of eperisone hydrochloride after percutaneous administration in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.11.005

Serotonin synthesis inhibition in olivo-cerebellar system attenuates harmaline-induced tremor in Swiss albino mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.11.005

Gas-liquid chromatographic method for the determination of tolperisone in human plasma: pharmacokinetic and comparative bioavailability studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.11.005

Tremorogenesis by LON-954 [N-carbamoyl-2-(2,6-dichlorophenyl) acetamidine hydrochloride]: evidence for the involvement of 5-hydroxytryptamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.11.005

Indanylidenes. 1. Design and synthesis of (E)-2-(4,6-difluoro-1-indanylidene)acetamide, a potent, centrally acting muscle relaxant with antiinflammatory and analgesic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.11.005

Relationship of the antispasticity effect of tizanidine to plasma concentration in patients with multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.11.005

Tizanidine in the treatment of spasticity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.11.005

Pharmacological studies on 6-amino-2-fluoromethyl-3-(O-tolyl)-4(3H)-quinazolinone (afloqualone), a new centrally acting muscle relaxant. (II) Effects on the spinal reflex potential and the rigidity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.11.005

Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist--a review of preclinical data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.11.005

Efficacy and tolerance of repeated oral doses of tolperisone hydrochloride in the treatment of painful reflex muscle spasm: results of a prospective placebo-controlled double-blind trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.11.005

Pharmacological properties of NK433, a new centrally acting muscle relaxant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.11.005

Sila-substitution--a useful strategy for drug design?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.11.005

Baclofen attenuates harmaline induced tremors in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.11.005

Drug therapy: spasticity (first of two parts).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2004.11.005

10.1016/J.VASCN.2004.11.005

7 January 2021

Identifiers

DOI

1 reference

24 December 2017

1 reference

24 December 2017